Global Small Molecule Active Pharmaceutical Ingredient Market Survey and Trend Research 2018

May 2018 | 89 pages | ID: G049E3BEDA7EN
99Strategy

Abstracts

SUMMARY

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Johnson Matthey, Siegfried Holding AG, Pfizer, Sanofi S.A., Bristol-Myers Squibb, Bristol-Myers Squibb, Boehringer Ingelheim GmbH, GlaxoSmithKline, Albany Molecular Research Inc., Bachem Holding AG, PCAS, Patheon N.V., AstraZeneca, Johnson & Johnson, Merck & Co, Inc., BASF SE, Catalent Inc., Teva Pharmaceuticals, Roche, Cambrex Corporation, GILEAD Science Inc. etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Small Molecule Active Pharmaceutical Ingredient Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

PART 4 KEY COMPANIES LIST

4.1 Johnson Matthey (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Siegfried Holding AG (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Pfizer (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Sanofi S.A. (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Bristol-Myers Squibb (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Bristol-Myers Squibb (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Boehringer Ingelheim GmbH (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 GlaxoSmithKline (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Albany Molecular Research Inc. (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Bachem Holding AG (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 PCAS (Company Overview, Sales Data etc.)
4.12 Patheon N.V. (Company Overview, Sales Data etc.)
4.13 AstraZeneca (Company Overview, Sales Data etc.)
4.14 Johnson & Johnson (Company Overview, Sales Data etc.)
4.15 Merck & Co, Inc. (Company Overview, Sales Data etc.)
4.16 BASF SE (Company Overview, Sales Data etc.)
4.17 Catalent Inc. (Company Overview, Sales Data etc.)
4.18 Teva Pharmaceuticals (Company Overview, Sales Data etc.)
4.19 Roche (Company Overview, Sales Data etc.)
4.20 Cambrex Corporation (Company Overview, Sales Data etc.)
4.21 GILEAD Science Inc. (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Small Molecule Active Pharmaceutical Ingredient Market 2012-2017, by Type, in USD Million
Table Global Small Molecule Active Pharmaceutical Ingredient Market 2012-2017, by Type, in Volume
Table Global Small Molecule Active Pharmaceutical Ingredient Market Forecast 2018-2023, by Type, in USD Million
Table Global Small Molecule Active Pharmaceutical Ingredient Market Forecast 2018-2023, by Type, in Volume
Table Johnson Matthey Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of Johnson Matthey (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Siegfried Holding AG Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of Siegfried Holding AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi S.A. Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim GmbH Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Albany Molecular Research Inc. Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of Albany Molecular Research Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bachem Holding AG Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of Bachem Holding AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table PCAS Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of PCAS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Patheon N.V. Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of Patheon N.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co, Inc. Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of Merck & Co, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BASF SE Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of BASF SE (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Catalent Inc. Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of Catalent Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceuticals Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of Teva Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cambrex Corporation Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of Cambrex Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GILEAD Science Inc. Overview List
Table Small Molecule Active Pharmaceutical Ingredient Business Operation of GILEAD Science Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Small Molecule Active Pharmaceutical Ingredient Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Small Molecule Active Pharmaceutical Ingredient Sales Revenue Share, by Companies, in USD Million
Table Global Small Molecule Active Pharmaceutical Ingredient Sales Volume 2012-2017, by Companies, in Volume
Table Global Small Molecule Active Pharmaceutical Ingredient Sales Revenue Share, by Companies in 2017, in Volume
Table Small Molecule Active Pharmaceutical Ingredient Demand 2012-2017, by Application, in USD Million
Table Small Molecule Active Pharmaceutical Ingredient Demand 2012-2017, by Application, in Volume
Table Small Molecule Active Pharmaceutical Ingredient Demand Forecast 2018-2023, by Application, in USD Million
Table Small Molecule Active Pharmaceutical Ingredient Demand Forecast 2018-2023, by Application, in Volume
Table Global Small Molecule Active Pharmaceutical Ingredient Market 2012-2017, by Region, in USD Million
Table Global Small Molecule Active Pharmaceutical Ingredient Market 2012-2017, by Region, in Volume
Table Small Molecule Active Pharmaceutical Ingredient Market Forecast 2018-2023, by Region, in USD Million
Table Small Molecule Active Pharmaceutical Ingredient Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Small Molecule Active Pharmaceutical Ingredient Industry Chain Structure
Figure Global Small Molecule Active Pharmaceutical Ingredient Market Growth 2012-2017, by Type, in USD Million
Figure Global Small Molecule Active Pharmaceutical Ingredient Market Growth 2012-2017, by Type, in Volume
Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region